Addressing Pediatric Cancer Disparities
Pediatric cancer is a global healthcare challenge with some 400,000 new cases annually in children and youth. In developed nations, over 80% are alive; in LMICs, that falls just short of 30%. Sanofi, a multinational healthcare player, responded to that disparity by making its corporate philanthropy about closing gaps in pediatric cancer care with initiatives like its Foundation S and its My Child Matters effort.
Sanofi Foundations: The Sanofi Collective
Foundation S - The Sanofi Collective, established in May 2022, is Sanofi's social impact division that is dedicated to shaping stronger futures for those in need. A “think tank” as much as a “do tank,” Foundation S brings in a range of partners in order to address critical healthcare challenges, with a central focus on pediatric cancer.
Some Important Objectives Are as Follows:
- Improve Pediatric Cancer Care: Ensuring a 60% survival rate in all pediatric cancer patients by 2030 as a vision shared by the World Health Organization (WHO).
- Establishing Strengthened Systems: Partnership with local healthcare structures, non-governmental bodies, as well as global stakeholders towards aligning resources with regional demands in a bid to enhance pediatric care.
- Galvanizing Collective Action: Leveraging Sanofi's strengths in partnership with partners in order to deliver effective healthcare drives.
My Child Matters: A Cornerstone Initiative
Established in 2005, My Child Matters is a flagship project of Foundation S with a vision towards improving survival in LMIC children with cancer. The project provides financial aid, technical input, and resources in a bid to promote equal access to care as well as diagnosis.
Impact and Achievements
- Impacts on Lives: Over 120,000 children have been supported by My Child Matters as of date.
- Capacity Building: The program has trained more than 50,000 healthcare practitioners, enhancing local capacities in pediatric cancer management.
- Increased Survival Rates: The participating nations have recorded a 5.1% survival rate improvement over a decade, which is more than 1,300 children saved each year.
Strategic Methods
- Local Solutions: Intervening in a way that is appropriate in each local context, bearing in mind that a one-size-fits-all strategy is not effective.
- Collaborative Networks: Alliances with government bodies, non-governmental organizations, and healthcare facilities in order to form a strong supportive network in pediatric oncology.
- Knowledge Sharing: Publishing over 200 scientific articles to disseminate findings and best practices globally.
Sanofi's Global Strategy in Pediatric Oncology
Beyond philanthropy, Sanofi integrates its corporate social responsibility with research and development to address pediatric cancer comprehensively.
Accelerating Research and Development
Sanofi CSR Childhood Cancer R&D is focused on innovative therapies in pediatric cancers with a vision towards:
- Breakthrough Treatments: Applying science-based ability in a bid to create more effective, more secure treatments for children.
- Speeding Up Clinical Trials: Closing gaps between adult and pediatric clinical trials in a bid to have new treatments available in a timely manner.
Joint Efforts
Sanofi engages proactively with global bodies in order to enhance its impact:
- WHO Partnership: Aligning with WHO Global Initiative on Childhood Cancer in order to enhance outcomes in LMICs.
- Global Fund and Bill Gates Foundation: Co-initiating the Climate x Health Catalytic Fund in order to develop climate-resilient healthcare systems, understanding that environmental determinants converge with healthcare outcomes.
A Vision for the Future
Sanofi's devotion towards eliminating childhood cancer is a testament to the power which can be realized through corporate philanthropy. Sanofi is continuing to:
- Improve Access to Care: Ensuring geographically located children have equal access to life-saving treatments.
- Empower Local Communities: Building local capacities in a bid to attain lasting pediatric healthcare advancements.
- Innovate for a Difference: Investing in research and collaborations that lead to pediatric oncology breakthroughs.
With its continuing multidisciplinary strategy, Sanofi is poised to make dramatic strides toward a future in which every child with cancer will have a fair shot at survival.
Learn More About Sanofi's Activities in Childhood Cancer
Visit the Foundation S – The Sanofi Collective to learn more about Sanofi's work and its efforts towards enhancing pediatric cancer care.
